Results 201 to 210 of about 453,877 (390)

Effective formation of major histocompatibility complex class II–peptide complexes from endogenous antigen by thyroid epithelial cells [PDF]

, 2000
Robert Maile, K. A. Elsegood, TC Harding, James B. Uney, Claire E. Stewart, George Banting, Colin Dayan   +6 more
openalex   +1 more source

Update on preclinical models of cancer therapy‐related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio‐Oncology, and the ESC Working Group on Cellular Biology of the Heart

European Journal of Heart Failure, EarlyView.
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the ...
Alessandra Ghigo, Pietro Ameri, Aarti Asnani, Edoardo Bertero, Rudolf A. de Boer, Dimitrios Farmakis, Arantxa González, Stephane Heymans, Borja Ibáñez, Teresa López‐Fernández, Alexander R. Lyon, Piero Pollesello, Amina Rakisheva, Konstantinos Stellos, Katrin Streckfuss‐Bömeke, Carlo Gabriele Tocchetti, Thomas Thum, Peter van der Meer, Eva Van Rooij, Piotr Ponikowski, Marco Metra, Giuseppe Rosano, Sophie Van Linthout   +22 more
wiley   +1 more source

Identification of murine H-2Db histocompatibility antigens in cells transfected with cloned H-2 genes [PDF]

, 1985
Ferluga, J., Festenstein, H., Schmidt, Walter, Weiss, Elisabeth H.   +3 more
core   +1 more source

Differing processing requirements of four recombinant antigens containing a single defined T-cell epitope for presentation by major histocompatibility complex class II [PDF]

, 2001
Lisa Colledge, Mei-yi Sun, Wei Lin, Clare Blackburn, Philip A. Reay   +4 more
openalex   +1 more source

Pro-inflammatory responses after peptide-based cancer immunotherapy

Heliyon
Therapeutic vaccinations are designed to prevent cancer by inducing immune responses against tumor antigens. in cancer cells, tumor-associated antigens (TAA) or tumor-specific (mutated) derived peptides are presented within the clefts of main ...
Hanie Mahaki, Hassan Ravari, Gholamhossein Kazemzadeh, Elham Lotfian, Rahele Amir Daddost, Amir Avan, Hamed Manoochehri, Mohsen Sheykhhasan, Reihaneh Alsadat Mahmoudian, Hamid Tanzadehpanah   +9 more
doaj  

INDUCTION OF CLASS II MAJOR HISTOCOMPATIBILITY ANTIGENS ON THYROID, ADULT PANCREATIC ISLET, AND FETAL PROISLET ALLOGRAFTS

, 1992
Hilary S. Warren, MICHELLE J. HODDER, W Allan, David Hume, Charmaine J. Simeonovic   +4 more
openalex   +1 more source

Skeletal Muscle Fibers Express Major Histocompatibility Complex Class II Antigens Independently of Inflammatory Infiltrates in Inflammatory Myopathies [PDF]

, 2001
Pernilla Englund, Eva Lindroos, Inger Nennesmo, Lars Klareskog, Ingrid E. Lundberg   +4 more
openalex   +1 more source

Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum.

EMBO Journal, 1996
Robert Busch, Isabelle Cloutier, R. Sékaly, G. J. Hämmerling   +3 more
semanticscholar   +1 more source

The transcription factor RIP140 regulates interferon γ signaling in breast cancer

International Journal of Cancer, Volume 157, Issue 1, Page 170-182, 1 July 2025.
What's new? Interferon γ (IFNγ) is a key player in breast cancer, with the potential to induce apoptosis and to shift tumors into a dormant state. However, it also may promote carcinogenesis and angiogenesis. In this study, transcriptomic analysis identified the transcription factor RIP140 as a key regulator of IFNγ signaling in breast cancer.
Stéphan Jalaguier, Axel Kuehn, Chloé Petitpas, Arnaud Dulom, Rémy Jacquemont, Cindy Assi, Sophie Sixou, Udo Jeschke, Jacques Colinge, Vincent Cavaillès   +9 more
wiley   +1 more source

Cyclic variation of major histocompatibility complex class II antigen expression in the human fallopian tube epithelium

, 1992
Greta Edelstam, Örjan Lundkvist, Lars Klareskog, Alex Karlsson‐Parra   +3 more
openalex   +1 more source